Gene · 3159
Papers3,810
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
921 to 940 of 3,810
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| OpenCell: Endogenous tagging for the cartography of human cellular organization. | Science | 2022 | 35271311 | PubTator, text mining | PubMed |
| Epigenetic Regulation in Uterine Fibroids-The Role of Ten-Eleven Translocation Enzymes and Their Potential Therapeutic Application. | Int J Mol Sci | 2022 | 35269864 | PubTator, text mining | PubMed |
| Diverse Roles and Targets of miRNA in the Pathogenesis of Testicular Germ Cell Tumour. | Cancers (Basel) | 2022 | 35267498 | PubTator, text mining | PubMed |
| Are Transcription Factors Plausible Oncotargets for Triple Negative Breast Cancers? | Cancers (Basel) | 2022 | 35267409 | PubTator, text mining | PubMed |
| Effect and Role of miR-196b in Ectopic Pregnancy. | J Healthc Eng | 2022 | 35265305 | PubTator, text mining | PubMed |
| Therapeutic targeting of the USP2-E2F4 axis inhibits autophagic machinery essential for zinc homeostasis in cancer progression. | Autophagy | 2022 | 35253629 | PubTator, text mining | PubMed |
| The Roles of Noncoding RNAs in the Development of Osteosarcoma Stem Cells and Potential Therapeutic Targets. | Front Cell Dev Biol | 2022 | 35252166 | PubTator, text mining | PubMed |
| Role of magnetic resonance-high intensity focused ultrasound (MR-HIFU) in uterine fibroids management: an updated systematic review and meta-analysis. | Wideochir Inne Tech Maloinwazyjne | 2022 | 35251392 | PubTator, text mining | PubMed |
| Unveiling genetic variants for age-related sarcopenia by conducting a genome-wide association study on Korean cohorts. | Sci Rep | 2022 | 35241739 | PubTator, text mining | PubMed |
| Integrated analysis of ceRNA network reveals potential prognostic Hint1-related lncRNAs involved in hepatocellular carcinoma progression. | World J Surg Oncol | 2022 | 35241097 | PubTator, text mining | PubMed |
| Pharmacological Perturbation of Mechanical Contractility Enables Robust Transdifferentiation of Human Fibroblasts into Neurons. | Adv Sci (Weinh) | 2022 | 35240008 | PubTator, text mining | PubMed |
| Ultra-high sensitivity mass spectrometry quantifies single-cell proteome changes upon perturbation. | Mol Syst Biol | 2022 | 35226415 | PubTator, text mining | PubMed |
| Construction of a circRNA-miRNA-mRNA Regulatory Network for Coronary Artery Disease by Bioinformatics Analysis. | Cardiol Res Pract | 2022 | 35223093 | PubTator, text mining | PubMed |
| Potential dual inhibitors of PCSK-9 and HMG-R from natural sources in cardiovascular risk management. | EXCLI J | 2022 | 35221836 | PubTator, text mining | PubMed |
| PACAP-38 Induces Transcriptomic Changes in Rat Trigeminal Ganglion Cells Related to Neuroinflammation and Altered Mitochondrial Function Presumably via PAC1/VPAC2 Receptor-Independent Mechanism. | Int J Mol Sci | 2022 | 35216232 | PubTator, text mining | PubMed |
| The Induced Expression of BPV E4 Gene in Equine Adult Dermal Fibroblast Cells as a Potential Model of Skin Sarcoid-like Neoplasia. | Int J Mol Sci | 2022 | 35216085 | PubTator, text mining | PubMed |
| Correction to 'High mobility group AT-hook 1 (HMGA1) is an important positive regulator of hepatitis B virus (HBV) that is reciprocally upregulated by HBV X protein'. | Nucleic Acids Res | 2022 | 35212376 | PubTator, text mining | PubMed |
| Environmental and Lifestyle Risk Factors in the Carcinogenesis of Gallbladder Cancer. | J Pers Med | 2022 | 35207722 | PubTator, text mining | PubMed |
| Novel Gene Signatures as Prognostic Biomarkers for Predicting the Recurrence of Hepatocellular Carcinoma. | Cancers (Basel) | 2022 | 35205612 | PubTator, text mining | PubMed |
| HMG Proteins from Molecules to Disease. | Biomolecules | 2022 | 35204819 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3159/papers?page=47